Provided by Tiger Trade Technology Pte. Ltd.

Beyond Air, Inc.

3.10
-0.0800-2.52%
Volume:35.83K
Turnover:111.83K
Market Cap:3.05M
PE:-0.05
High:3.19
Open:3.16
Low:3.06
Close:3.18
52wk High:55.60
52wk Low:3.06
Shares:984.40K
Float Shares:876.00K
Volume Ratio:0.51
T/O Rate:4.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-62.8755
EPS(LYR):-80.1092
ROE:-519.51%
ROA:-57.45%
PB:1.53
PE(LYR):-0.04

Loading ...

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

GlobeNewswire
·
Apr 15

Beyond Air faces Nasdaq delisting after shares trade below $1 bid price

Reuters
·
Apr 11

Beyond Air CEO Steve Lisi resigns; CCO Robert Goodman named CEO

Reuters
·
Apr 02

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences

Reuters
·
Apr 02

Beyond Air Expands Commercial Access for Lungfit® Ph Through a Purchasing Agreement With a Top 3 National Group Purchasing Organization (Gpo)

THOMSON REUTERS
·
Apr 01

Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)

GlobeNewswire
·
Apr 01

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 27

BTIG Sticks to Its Hold Rating for Beyond Air (XAIR)

TIPRANKS
·
Mar 27

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

TIPRANKS
·
Mar 27

Press Release: Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

Dow Jones
·
Mar 27

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 18

Beyond Air Unit Reports Positive Safety Data From Phase 1 Intratumoral Nitric Oxide Monotherapy

MT Newswires Live
·
Mar 18

Beyond Air subsidiary reports signs of clinical activity from UNO trial

TIPRANKS
·
Mar 18

Beyond Cancer reports early clinical activity in Phase 1 UNO solid tumor trial

Reuters
·
Mar 18

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile With Interim Data From Phase 1 Uno Trial

THOMSON REUTERS
·
Mar 18

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR)

TIPRANKS
·
Mar 12

Beyond Air CEO Steve Lisi to speak at Roth Conference fireside chat

Reuters
·
Mar 11

Beyond Air to Participate in the 38th Annual Roth Conference in March

GlobeNewswire
·
Mar 11

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 10

Beyond Air announces termination of NeuroNOS agreement with XTL

TIPRANKS
·
Mar 10